MARATTO

article · Head and Neck Pathology

Surrogate Immunohistochemical Markers of Proliferation and Embryonic Stem Cells in Distinguishing Ameloblastoma from Ameloblastic Carcinoma

20243 citationsOpen accessStellenbosch University

Abstract

Ki-67 IHC as a proliferation marker, particularly when assessed via automated methods, was helpful in distinguishing AC from AB cases. In contrast to other studies, surrogate IHC markers of embryonic stem cells, SOX2, OCT4 and GPC-3, were unreliable in distinguishing the two entities.

Research topics

  • Oral and Maxillofacial Pathology
  • Head and Neck Surgical Oncology
  • dental development and anomalies

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1007/s12105-024-01704-8

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.